Alde Medi Hosts Groundbreaking 2025 Annual Meeting, Reinforces Commitment to Global Healthcare Innovation
India PR Distribution
New Delhi [India], June 23: In a bold step towards redefining the future of healthcare marketing & manufacturing, Alde Medi Impex, a trusted name in the pharmaceutical world, hosted its 25th annual Business Conference 2025. The event brought together healthcare professionals, pharma leaders, and strategic partners under one roof to share insights, foster collaboration, and unveil what the future holds for Alde Medi and the broader healthcare landscape.
Far beyond just a milestone, the conference reflected Alde Medi's growing role--not only as a manufacturer but as a driver of innovation, meaningful partnerships, and global trust in healthcare solutions.
A Glimpse into the Future: Key Announcements at the Business Conference
The energy at the conference was electric, and the announcements made reflected Alde Medi's forward-thinking approach to growth, quality, and innovation. Some of the standout moments included:
* A 35% Surge in Domestic Growth
Alde Medi recorded a strong 35% growth in India's domestic market driven by focused strategies, deep market understanding, and growing trust among hospitals, institutions, and healthcare providers.
* Launching a New-Gen Sterile Injectables Facility
Plans for a state-of-the-art sterile injectables facility were unveiled, scheduled for completion by December 2025. Designed to meet the most stringent global standards - EUROPE, SAUDI FDA, and ANVISA, this facility will raise the bar for quality, precision, and compliance in Indian pharma manufacturing.
* ALDEVIT Gold Climbs to the Top
ALDEVIT Gold, the company's flagship multivitamin, was recognised as India's 47th top brand among over 1,600 multivitamin products (as per IMS Health data). A proud achievement that reflects growing demand and credibility in the wellness segment.
* Exports Skyrocket by 80%
Alde's exports soared by 80% in 2024, marking a major leap in its global footprint. Now officially a Government Recognized Export House, Alde Medi has over 100 product registrations across 20+ countries and active exports in 35+ global markets with team size of more than 100 professionals contributing at different part of the world . The next big leap: entering Brazil and Mexico with plans to file 200+ new dossiers in 2025 in various countries.
* Somediza Lifesciences: Generic Division Launched
With the launch of Somediza Lifesciences, Alde enters the generic space backed by a clear goal to become one of India's most quality-focused generic pharma companies. The division aims to make trusted, affordable medicines accessible to all.
* Critical Care Division Doubles Its Impact
2024 saw 100%+ growth in Alde's Critical Care Division, which now supplies to top hospitals like Metro Group and Venkateshwara Hospital in Delhi. The next phase of growth will focus on expanding into MAX Healthcare, Yashoda, and Kailash Hospitals, ensuring critical treatments are within reach when they're needed the most.
Alde Medi: More Than a Manufacturer--A Platform for Ideas, Impact, and Innovation
The conference wasn't just about business, it was a space for meaningful conversations and forward-looking ideas. Topics explored included:
* The evolving regulatory landscape across countries
* How AI and automation are reshaping pharmaceutical production
* Best practices in clean, sustainable manufacturing
* Opportunities for strategic partnerships across borders
* Innovative product portfolio for next 2 years defined
* Market penetration strategies were discussed
It was a powerful reminder that healthcare is no longer local, it's global. And Alde Medi is ready to lead from the front.
About Alde Medi Impex: A Legacy of Innovation and Trust
Founded in 1997 , Alde Medi Impex has grown from a humble beginning into a globally respected name in pharmaceutical manufacturing. Backed by WHO, GLP, and ISO certifications, the company specialises in injectable dosage forms including Liquid Injections, Dry Powder Injections, and Lyophilized Injections delivering life-saving sterile solutions to both Indian and global markets.
But Alde Medi is more than just a manufacturing powerhouse. It has earned its reputation as a reliable healthcare partner, with a focus on quality, compliance, and scalable operations. In addition to pharmaceuticals, the group is also building diversified platforms that cater to modern needs, across travel, shopping, and everyday conveniences.
Our Ventures:
* Alde Expression - A PIC/s & EU-GMP certified manufacturing facility
* Alde Bazaar - A comprehensive e-commerce platform
* Truvel - A smart travel booking platform
Leadership Speaks: Building a Future That Cares
"With each vial, every solution we make carries a promise--our promise to protect lives."
-- Chairman, Alde Group
The leadership at Alde Medi made it clear: while the company is scaling rapidly, it remains deeply rooted in its values, compassion, quality, and purpose. A people-first culture, where learning, innovation, and accountability go hand-in-hand, continues to drive the company's momentum forward.
From One Room to the World: A Timeline of Growth
* 1997- : Alde Medi was born with a five-member team and a big dream
* 1997-2012: Expanded steadily across Uttar Pradesh and North India
* 2012- 2018: Manas Rastogi ( B.Tech in Biotechnology , MBA in Marketing from UK ) joined as marketing director . Exponential growth in domestic market - team size , new product launches , diversification to cardiology / neurology / metabolic products . These 6 years made alde medi one of the renowned name in north indian pharmaceutical industry.
* 2019-2020: Manas promoted as CEO, Array of expansion and diversification began, transformation of alde medi impex limited to Alde group.
Group companies : Globezza biotech ( nutraceutical division ) , somediza lifesciences ( generic division ) , Alde export ( international division ) , Alde medi ( marketing division ) , Alde real estate , Truvel services ( travel arm ) , Alde Bazaar ( E commerce )
* 2020-2025: Ambitious roadmap targeting 300% growth, global market expansion, and breakthrough innovations
Looking Ahead
The Business Conference 2025 was more than a corporate event, it was a celebration of shared purpose, progress, and possibility. With a clear focus on healthcare accessibility, sustainable innovation, and global partnerships, Alde Medi is building something bigger than just a business.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
2 days ago
- Time of India
Drone maker Raphe mPhibr raises $100 million in round led by Silicon Valley's General Catalyst
Academy Empower your mind, elevate your skills Noida-based drone manufacturing startup Raphe mPhibr has raised $100 million in an equity funding round led by Silicon Valley investor General Catalyst , the company said in a press release. The round, which values the nine-year old startup at nearly $900 million, also saw participation from existing investors including stock market investor Amal Parikh, Think Investments and other family what is among the largest financing rounds for an Indian military drone maker, the $100 million raise takes the company's total funding to $145 million. According to Venture Intelligence, Indian drone makers have raised a total of $151 million in the last five years.'The products emerging from Raphe mPhibr are already making a tangible impact on the ground, signalling what we believe will be a monumental shift. Their work is not only accelerating India's path to strategic self-reliance but also embodies the essence of our 'Global Resilience' thesis at General Catalyst – building for a future that is secure, sovereign, and sustainable,' said Neeraj Arora, managing director at General Catalyst. The investor has backed several other defence tech startups, including US-based companies such as Anduril Industries and Vannevar Labs, and Europe-based AI defence tech company funding comes at a time when the demand for locally made military unmanned aerial vehicles (UAV) has increased — as witnessed recently during the skirmish between India and Pakistan that saw both countries deploy drone per a Reuters report in May, which cited Drone Federation of India's president Smit Shah, India plans to invest heavily in local industry and could spend as much as $470 million on UAVs over the next 12 to 24 months, roughly three times pre-conflict in 2016 by Vivek Mishra and Vikash Mishra, the startup designs and manufactures a range of unmanned aerial vehicles (UAVs), which includes a drone swarm platform, a high-altitude logistics drone, a surveillance drone and a compact maritime patrol system. The company said that several of these systems are already being used by Indian defence to Tracxn data, Raphe mPhibr, which competes with the likes of listed player IdeaForge, Garuda Aerospace and Tata Advanced Systems, reported revenue of Rs 86 crore in fiscal 2024 – more than double of Rs 42 crore in FY23. The company also posted a profit of Rs 9 crore in mPhibr was among the 12 drone manufacturers shortlisted by the central government in 2022 for the production-linked incentive scheme for drones and drone components.
Time of India
4 days ago
- Time of India
Chaos at Doha, Dubai airports, flyers stuck: Airlines resume Gulf, Europe flights; UAE, Qatar airspaces reopen
NEW DELHI: Flights to and from West Asian and European hubs resumed Tuesday after closures of UAE and Qatari airspaces triggered mass disruptions across global aviation late Monday night. Key airports - Dubai, Doha, and Abu Dhabi - began reopening in the early hours, stabilising operations across the region. West Asia is India's primary air corridor to the world, with Dubai, Doha, and Abu Dhabi serving as essential transit points for millions of travellers. Air India said it would "progressively resume flights to the region starting Tuesday", with most Gulf operations expected to be back from June 25. Europe-bound flights, previously grounded, are also being reinstated, while services to the US East Coast and Canada "will resume at the earliest opportunity". Hundreds of flights were affected Monday night as critical West Asian hubs, including Sharjah, shut down - a fallout of the Iran-Israel conflict. Aircraft en route from Indian cities were diverted mid-air, returned to origin, or held on the tarmac as operators scrambled for clarity. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Perdagangkan CFD Emas dengan Broker Tepercaya IC Markets Mendaftar Undo Major players serving the India-Gulf corridor - Emirates, IndiGo, Air India, Qatar Airways, Etihad, Akasa, SpiceJet, Air Arabia - reported widespread operational halts. "Some flights may experience delays or cancellations due to consequential impacts and extended re-routings or flight times," an Air India spokesperson said. "We are committed to minimising disruptions and restoring schedule integrity. Air India will continue to avoid airspaces assessed as unsafe at any given time." Air India Express announced a staggered return starting Tuesday. Its first West Asia flight, Delhi to Muscat, was set to depart Tuesday, followed by routes from Mumbai, Kozhikode, and Jaipur to Muscat, Riyadh, and Jeddah. Flights to Dubai, Abu Dhabi, Sharjah, Al Ain, Ras Al Khaimah, and other cities will resume Wednesday. "Guests are advised to check their flight status," the airline said. IndiGo reported stabilised operations. "Flight operations into, out of, and through the Gulf countries have stabilised and are operating as scheduled. However, as airspace over Iran remains restricted, some flights may take alternative routes, which could result in longer travel times," the airline said. Qatar Airways said operations resumed after Qatari airspace reopened. "Our focus is to help passengers return home or reach their onward journey safely. We are working tirelessly to restore operations," the airline said. Stay informed with the latest business news, updates on bank holidays and public holidays . AI Masterclass for Students. Upskill Young Ones Today!– Join Now
Time of India
5 days ago
- Time of India
Stocks Feel the West Asia Heat, But Don't Boil Over
Indian equities retreated Monday after the US risked its own billion-dollar-plus military assets to pound subsurface Iranian nuclear sites over the weekend, but the broadest gauges erased initial losses to end about half a percent lower following modest gains in crude oil prices . 'Markets will closely watch for further escalation in West Asia that could affect oil supply and pricing,' said Nilesh Shah, MD, Kotak Mahindra AMC. 'It will be fair to assume the risk aversion will rise with escalation and will have an adverse impact on markets.' The Sensex shed 511.36 points, or 0.6%, at 81,896, while the Nifty declined 140.50 points, or 0.5%, to settle at 24,670. Technology bellwethers Infosys, HCL Technologies and TCS, which together account for the second biggest Nifty weighting, fell 1-3% and led the decliners. The technology pack drifted after the revenue guidance by Accenture, the world's largest services company by market value, fell short of market expectations. Rupee, Hedging Costs Hold Steady9 Both indices, which fell as much as 1% earlier in the day, erased a portion of the losses on expectations that the Iranian response to the US strikes would not be severe. Tehran's threat that it would block the Strait of Hormuz —a critical route for the global oil trade—has raised both the geopolitical risk quotient and investor caution for emerging markets susceptible to fuel price fluctuations. The measured advance in oil prices on Monday reflected market expectations of a restrained reaction by Iran to the US attacks. Brent crude futures rose 0.8% to $77.60 a barrel after opening above $80. Bonds—from US Treasuries to European securities—weakened on concerns higher oil prices could raise inflationary pressures. Gold futures advanced 0.2% at $3,393.40 per ounce in New York. 'Recent events suggest the US and Israel have established airspace dominance and inflicted significant damage on Iran's ability to counter-attack,' said Mihir Vora, CIO, Trust AMC. 'As a result, it may not be easy to disrupt the sea-traffic movement in the Gulf.' Vora said as long as oil stays within the $65-86 range, India can manage the volatility. 'Only if it spikes to extreme levels—like $100-120—can oil create problems,' he said. Elsewhere in Asia, most markets ended weak. Japan fell 0.1%, South Korea declined 0.2%, Indonesia dipped 1.7% and Taiwan dropped 1.4%. China and Hong Kong rose 0.7% each. The pan-Europe index Stoxx 600 closed 0.28% lower. The pan-Europe index Stoxx 600 was down 0.26% when this report was going into publication. At home, the Nifty Midcap 150 index rose 0.4%, while the Nifty Smallcap 250 advanced 0.8%. Of the total 4,240 stocks traded on the BSE, 2,198 declined and 1,862 advanced. The India VIX—the market's fear gauge—rose 2.74% to 14.05, indicating elevated nervousness among traders.
